AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE 
 Depository Receipt · US05337M1045  · AVDL  · A2DJR8  (XNMS)
                    No Price
                
            04.11.2025 14:52
        
Current Prices from AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change | 
|---|---|---|---|---|---|
![]() NASDAQ  | 
                                AVDL
                              | 
                                USD
                              | 
                                04.11.2025 14:52
                              | 
                                18,94 USD
                              | 0,01 USD  
        +0,08 %
      | 
        Invested Funds
        
 The following funds have invested in AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE:
Fund  | Vol. in million 16,80  | Percentage (%) 0,04 %  | 
        Company Profile for AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE Depository Receipt
    
 Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
 Company Data
Name AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE
 Company Avadel Pharmaceuticals plc
 Symbol AVDL
 Website 
                            https://www.avadel.com
                        
 Primary Exchange 
                        NASDAQ/NMS (GLOBAL MARKET)
                    
 WKN A2DJR8
 ISIN US05337M1045
 Asset Class Depository Receipt
     Sector Healthcare
 Industry Drug Manufacturers - Specialty & Generic
 CEO Gregory J. Divis Jr.
 Market Capitalization 2 Mrd.
 Country Ireland
 Currency USD
 Employees 0,2 T
 Address 10 Earlsfort Terrace, 2 Dublin
 IPO Date 1996-06-07
ID Changes
| Date | From | To | 
|---|---|---|
| 14.01.2017 | FLML | AVDL | 
Ticker Symbols
| Name | Symbol | 
|---|---|
| NASDAQ | AVDL | 
            More Shares
            
 
                Investors who hold AVADEL PHARMACEUTICALS PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE also have the following shares in their portfolio:
            
            The financial platform MoneyPeak tracks and analyzes investments and portfolios.
 From securities portfolios to crypto purchases.
            
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
 Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.




